Alzheimer’s Disease, Neuroinflammation and Antimicrobial Resistance
As diverse as Alzheimer's Disease (AD), Neuroinflammation and Antimicrobial Resistance (AMR) are, they carry in common a high burden on our population already now with a most gloomy outlook. Prominent failures in AD trials and a dried-out antibiotics pipeline are the drivers for these worrisome developments. At discoveric bio we take the challenge to developing innovative solutions in these areas applying disruptive bi- and multi-specific antibody technologies with the aim to deliver safe and effective therapies to patients.
